Oppenheimer & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Oppenheimer & Co’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,326	Closed	-$229K	–	1635
2015 Q1	$229K	Buy	+1,326	New	+$195K	0.01%	1234
2013 Q4	–	Sell	-16,872	Closed	-$1.13M	–	1499
2013 Q3	$1.13M	Buy	+16,872	New	+$1.16M	0.04%	487

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Oppenheimer & Co's SLXP Position: Q2 2015 in Review

Oppenheimer & Co sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,326 shares — an estimated $229K sold.

Oppenheimer & Co first reported a position in SLXP in Q3 2013 and held it in 2 quarters. The position peaked at $1.13M in Q3 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Oppenheimer & Co reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Oppenheimer & Co sold 1,326 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $229K.
Oppenheimer & Co first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 2 quarters.
Oppenheimer & Co's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.13M in Q3 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.